Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix
dc.contributor.author | Alvarez, Ronald D. | en_US |
dc.contributor.author | Soong, Seng-Jaw | en_US |
dc.contributor.author | Kinney, Walter K. | en_US |
dc.contributor.author | Reid, Gary C. | en_US |
dc.contributor.author | Schray, Mark F. | en_US |
dc.contributor.author | Podratz, Karl C. | en_US |
dc.contributor.author | Morley, George W. | en_US |
dc.contributor.author | Shingleton, Hugh M. | en_US |
dc.date.accessioned | 2006-04-07T20:39:25Z | |
dc.date.available | 2006-04-07T20:39:25Z | |
dc.date.issued | 1989-11 | en_US |
dc.identifier.citation | Alvarez, Ronald D., Soong, Seng-Jaw, Kinney, Walter K., Reid, Gary C., Schray, Mark F., Podratz, Karl C., Morley, George W., Shingleton, Hugh M. (1989/11)."Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix." Gynecologic Oncology 35(2): 130-135. <http://hdl.handle.net/2027.42/27695> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6WG6-4C52M53-K5/2/9cb608a5ecab16d20d100df551c4a663 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/27695 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2807001&dopt=citation | en_US |
dc.description.abstract | In a retrospective study conducted at the University of Alabama at Birmingham, the University of Michigan, and the Mayo Clinic, 185 patients with previously untreated FIGO stage IB and IIA squamous cell carcinoma of the cervix were found to have nodal metastasis at the time of radical hysterectomy and pelvic lymphadenectomy. Of these patients, 103 received adjuvant pelvic irradiation. Cancer recurred in 76 patients; the median time to recurrence was 3.1 years. The prognostic significance of patient age, clinical stage, lesion diameter, number and location of nodal metastases, and use of adjuvant radiation therapy was determined by multivariate analysis. Only patient age (P = 0.0006), lesion diameter (P P = 0.0004) were noted to be significant factors in determining overall survival. Rates of recurrence were also related to these factors. Employment of these significant variables led to identification of four risk groups. In general, patients with small cervical lesions (diameter 4 cm) and more than two involved nodes fell into the high-risk category. All other patients were categorized into intermediate-risk groups. Ten-year survival was 92% in the low-risk group (n = 13), 70% in the low-intermediate-risk group (n = 66), 56% in the high-intermediate-risk group (n = 66), and 13% in the high-risk group (n = 20). This risk group classification identifies subgroups of early-stage cervical carcinoma patients found to have nodal metastasis at the time of radical hysterectomy that warrant appropriately selected adjuvant therapy. | en_US |
dc.format.extent | 575217 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Otolaryngology | en_US |
dc.subject.hlbsecondlevel | Ophthalmology | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbsecondlevel | Obstetrics and Gynecology | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan, Ann Arbor, Michigan 48109, U.S.A. | en_US |
dc.contributor.affiliationum | University of Michigan, Ann Arbor, Michigan 48109, U.S.A. | en_US |
dc.contributor.affiliationother | University of Alabama, at Birmingham, Birmingham, Alabama 35294, U.S.A. | en_US |
dc.contributor.affiliationother | University of Alabama, at Birmingham, Birmingham, Alabama 35294, U.S.A. | en_US |
dc.contributor.affiliationother | Mayo Clinic, Rochester, Minnesota 55905, U.S.A. | en_US |
dc.contributor.affiliationother | Mayo Clinic, Rochester, Minnesota 55905, U.S.A. | en_US |
dc.contributor.affiliationother | Mayo Clinic, Rochester, Minnesota 55905, U.S.A. | en_US |
dc.contributor.affiliationother | University of Alabama, at Birmingham, Birmingham, Alabama 35294, U.S.A. | en_US |
dc.identifier.pmid | 2807001 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/27695/1/0000081.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0090-8258(89)90029-2 | en_US |
dc.identifier.source | Gynecologic Oncology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.